Application
Stable Labelled Ustekinumab is used to quantify Ustekinumab
Specific labelling
Arginine: 13C6,15N4>99%
Lysine: 13C6,15N2, >99%
Description
Ustekinumab, (brand name Stelara) is a monoclonal antibody, for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis, targeting both IL-12 and IL-23.
This product is for research use only and is not intended for diagnostic or therapeutic use.
For any quantities, please contact us
Custom clearance and freight insurance costs to be borne by the customer.
This product is licensed under U.S. Patent No. 7,396,688 and foreign counterparts from E. I. du Pont de Nemours and Company. The purchase of this product conveys to the buyer the nontransferable right to use the purchased amount of the product for research and development only. Information about licenses for other uses is available from: E. I. du Pont de Nemours and Company; Attn: Associate Director, Commercial Development; DuPont Experimental Station E268; 200 Powdermill Rd.; Wilmington, DE 19803; 1-877-881-9787 (voice), 1-302-695-1437 (fax), licensing@dupont.com.
